- Home
- AMRN vs LANV Comparison
AMRN vs LANV Comparison
Compare AMRN & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- LANV
- Stock Information
- Founded
- AMRN 1989
- LANV 2015
- Country
- AMRN Ireland
- LANV China
- Employees
- AMRN N/A
- LANV N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- LANV Blank Checks
- Sector
- AMRN Health Care
- LANV Finance
- Exchange
- AMRN Nasdaq
- LANV Nasdaq
- Market Cap
- AMRN 302.0M
- LANV 244.4M
- IPO Year
- AMRN 1993
- LANV N/A
- Fundamental
- Price
- AMRN $19.10
- LANV $2.16
- Analyst Decision
- AMRN Strong Sell
- LANV
- Analyst Count
- AMRN 1
- LANV 0
- Target Price
- AMRN $12.00
- LANV N/A
- AVG Volume (30 Days)
- AMRN 94.0K
- LANV 52.7K
- Earning Date
- AMRN 10-29-2025
- LANV 08-29-2025
- Dividend Yield
- AMRN N/A
- LANV N/A
- EPS Growth
- AMRN N/A
- LANV N/A
- EPS
- AMRN N/A
- LANV N/A
- Revenue
- AMRN $219,361,000.00
- LANV $341,783,911.00
- Revenue This Year
- AMRN N/A
- LANV N/A
- Revenue Next Year
- AMRN N/A
- LANV $6.90
- P/E Ratio
- AMRN N/A
- LANV N/A
- Revenue Growth
- AMRN N/A
- LANV N/A
- 52 Week Low
- AMRN $7.08
- LANV $1.32
- 52 Week High
- AMRN $20.43
- LANV $2.69
- Technical
- Relative Strength Index (RSI)
- AMRN 82.57
- LANV 53.47
- Support Level
- AMRN $15.24
- LANV $2.02
- Resistance Level
- AMRN $20.43
- LANV $2.18
- Average True Range (ATR)
- AMRN 0.80
- LANV 0.11
- MACD
- AMRN 0.39
- LANV 0.01
- Stochastic Oscillator
- AMRN 75.82
- LANV 62.50
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.